News
Humana Announces Nearly $1 Million in Financial Relief to Six Oklahoma Community Service Organizations
As Oklahomans face extraordinary challenges during difficult times, leading health and well-being company Humana Inc. (NYSE: HUM) today announced grants totaling nearly $1 million to six nonprofit
Pfizer and BioNTech Receive CHMP Positive Opinion for their COVID-19 Vaccine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive
Quidel Receives Emergency Use Authorization for QuickVue® SARS Rapid Antigen Test for COVID-19 Diagnosis
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel
Agilent Announces Webcasts for Investment Community
Agilent Technologies Inc. (NYSE: A) today announced dates and times of two upcoming webcasts for the investment community.
Goldman Sachs Healthcare CEOs Unscripted Conference
Tuesday, Jan. 5
PerkinElmer to Present at J.P. Morgan Healthcare Conference
PerkinElmer, Inc. (NYSE: PKI), a global leader committed to innovating for a healthier world, today announced that the Company will present at the annual J.P. Morgan Healthcare Conference on
Integra LifeSciences Selects Veeva Vault CDMS for Clinical Data Management
Veeva Systems (NYSE: VEEV) today announced that Integra LifeSciences, a global leader in regenerative technologies, neurosurgical, and extremity orthopedic solutions, has selected Veeva Vault CDMS
Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
Veeva Systems (NYSE: VEEV) today announced that Samsung Biologics, an award-winning global contract development and manufacturing organization (CDMO), has adopted Veeva Vault QMS to streamline
Samsung Biologics Adopts Veeva Vault QMS to Unify Quality Management
Veeva Systems (NYSE: VEEV) today announced that Samsung Biologics, an award-winning global contract development and manufacturing organization (CDMO), has adopted Veeva Vault QMS to streamline
Agilent Receives Multiple Innovation Awards
Agilent Technologies Inc. (NYSE: A) today announced that both the NanoDis System and the innovative new style polychromator in the 5800 and 5900 ICP-OES have received Innovation Awards from The
U.S. CDC Committee of Independent Health Experts Recommends Vaccination with Pfizer and BioNTech COVID-19 Vaccine for Persons Ages 16 Years and Older
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Centers for Disease Control and Prevention’s (CDC) Advisory Committee on Immunization Practices (ACIP) voted
Pfizer and BioNTech Celebrate Historic First Authorization in the U.S. of Vaccine to Prevent COVID-19
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of the mRNA vaccine, BNT162b2, against
Agilent Releases 2019 Corporate Social Responsibility Report
Agilent Technologies Inc. (NYSE: A) today launched its 19th annual Corporate Social Responsibility (CSR) report, highlighting innovations and advancements achieved in 2019 and sharing the company’s
Pfizer Declares First-Quarter 2021 Dividend
The board of directors of Pfizer Inc. (NYSE:PFE) declared a 39-cent first-quarter 2021 dividend on the company’s common stock, payable March 5, 2021, to holders of the Common Stock of record at the
Pfizer and BioNTech Receive FDA Advisory Committee Vote Supporting Potential First Emergency Use Authorization for Vaccine to Combat COVID-19 in the U.S.
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced today that the U.S. Food and Drug Administration’s (FDA) Vaccines and Related Biological Products Advisory Committee (VRBPAC) voted
Quidel Corporation CEO Douglas Bryant Named Executive of the Year in MedTech Dive Awards For 2020
Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that Quidel’s
Pfizer and BioNTech Announce Publication of Results from Landmark Phase 3 Trial of BNT162b2 COVID-19 Vaccine Candidate in The New England Journal of Medicine
Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) today announced that the New England Journal of Medicine has published safety and final efficacy results from the pivotal Phase 3 trial of
Humana Announces New Primary Care Value-Based Model
Leading health and well-being company Humana Inc. (NYSE: HUM) today announced an expansion of its value-based program portfolio with the forthcoming launch of the Primary Care First (PCF) model. It
Waters Corporation Appoints Pearl S. Huang to Board of Directors
Waters Corporation (NYSE:WAT) today announced that Dr. Pearl S. Huang, President and CEO of Cygnal Therapeutics and venture partner at Flagship Pioneering, has been appointed as a Director of
Huntington’s St. Mary’s Medical Center and Humana Announce Medicare Network Agreement
St. Mary’s Medical Center, one of West Virginia’s largest health care facilities, and leading health and well-being company Humana Inc. (NYSE: HUM) announced today they have signed an agreement to
Simbec-Orion rationalisiert Studiendurchführung mit klinischen Anwendungen von Veeva
Veeva Systems (NYSE: VEEV) gab heute bekannt, dass Simbec-Orion, eine auf klinische Pharmakologie, Onkologie und seltene Krankheiten spezialisierte Full-Service-Vertragsforschungsorganisation
Waters Collaborates with Dr. Sunghwan Kim of Kyungpook National University to Advance Precision Analysis of Complex Chemical Compounds
Waters Corporation (NYSE:WAT) has formally expanded its long-standing, collaborative relationship with Dr. Sunghwan Kim of Kyungpook National University to further explore the use of Waters’
U.S. FDA Accepts for Priority Review the Biologics License Application for Pfizer’s Investigational 20-valent Pneumococcal Conjugate Vaccine for Adults 18 Years of Age and Older
Pfizer Inc. (NYSE:PFE) today announced that the U.S. Food and Drug Administration (FDA) accepted for priority review a Biologics License Application (BLA) for its 20-valent pneumococcal conjugate
Illumina and Harvard Pilgrim Health Care Expand Access to Whole-Genome Sequencing for Genetic Disease Testing
Illumina, Inc. (Nasdaq: ILMN) and Harvard Pilgrim Health Care announce a risk-sharing agreement to make whole-genome sequencing (WGS) available to certain Harvard Pilgrim members, effective January
Simbec-Orion Streamlines Trial Execution with Veeva Clinical Applications
Veeva Systems (NYSE: VEEV) today announced that Simbec-Orion, a full-service contract research organization (CRO) specialized in clinical pharmacology, oncology, and rare diseases, is adopting
Simbec-Orion Streamlines Trial Execution With Veeva Clinical Applications
Veeva Systems (NYSE: VEEV) today announced that Simbec-Orion, a full-service contract research organization (CRO) specialized in clinical pharmacology, oncology, and rare diseases, is adopting